BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33649830)

  • 1. Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review).
    Zhang SQ; Pan SM; Liang SX; Han YS; Chen HB; Li JC
    Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker discovery of nasopharyngeal carcinoma by proteomics.
    Xiao L; Xiao T; Wang ZM; Cho WC; Xiao ZQ
    Expert Rev Proteomics; 2014 Apr; 11(2):215-25. PubMed ID: 24611579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the expression of miR150 and FOXO4 and the local recurrence and metastasis of nasopharyngeal carcinoma after intensive radiotherapy.
    Liu B; Tan Z; Jiang Y; Chen Y; Chen Y; Ling K
    J BUON; 2018; 23(6):1671-1678. PubMed ID: 30610793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omics-based identification of biomarkers for nasopharyngeal carcinoma.
    Janvilisri T
    Dis Markers; 2015; 2015():762128. PubMed ID: 25999660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
    Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
    PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
    Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
    Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2.
    Chen S; Youhong T; Tan Y; He Y; Ban Y; Cai J; Li X; Xiong W; Zeng Z; Li G; Yi M; Liu W; Xiang B
    Carcinogenesis; 2020 Jul; 41(6):723-733. PubMed ID: 31665243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E3-ligase Skp2 predicts poor prognosis and maintains cancer stem cell pool in nasopharyngeal carcinoma.
    Wang J; Huang Y; Guan Z; Zhang JL; Su HK; Zhang W; Yue CF; Yan M; Guan S; Liu QQ
    Oncotarget; 2014 Jul; 5(14):5591-601. PubMed ID: 25015320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma protein-based signature predicts distant metastasis and induction chemotherapy benefit in Nasopharyngeal Carcinoma.
    Liang Y; Li J; Li Q; Tang L; Chen L; Mao Y; He Q; Yang X; Lei Y; Hong X; Zhao Y; He S; Guo Y; Wang Y; Zhang P; Liu N; Li Y; Ma J
    Theranostics; 2020; 10(21):9767-9778. PubMed ID: 32863958
    [No Abstract]   [Full Text] [Related]  

  • 10. ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma.
    Cai J; Chen S; Yi M; Tan Y; Peng Q; Ban Y; Yang J; Li X; Zeng Z; Xiong W; McCarthy JB; Li G; Li X; Xiang B
    Carcinogenesis; 2020 Sep; 41(9):1282-1293. PubMed ID: 31826234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-214-3p predicts nasopharyngeal carcinoma recurrence or metastasis.
    Wang J; Xu Y; Wang J; Ying H
    Clin Chim Acta; 2020 Apr; 503():54-60. PubMed ID: 31926154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.
    Wu Q; Xiang M; Wang K; Chen Z; Long L; Tao Y; Liang Y; Yan Y; Xiao Z; Qiu S; Yi B
    Curr Cancer Drug Targets; 2020; 20(8):624-637. PubMed ID: 32329689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome Profile of Next-Generation Sequencing Data Relate to Proliferation Aberration of Nasopharyngeal Carcinoma Patients in Indonesia.
    Setiasari DW; Rahmawati G; Sudigyo D; Poluan RH; Sesotyosari SL; Wardana T; Indrasari SR; Herawati C; Heriyanto DS; Astuti I; Afiahayati -; Haryana SM
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2585-2591. PubMed ID: 32986356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
    Huang Q; Hou S; Zhu X; Liu S
    World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma.
    Wang C; Jiang S; Ke L; Zhang L; Li D; Liang J; Narita Y; Hou I; Chen CH; Wang L; Zhong Q; Ling Y; Lv X; Xiang Y; Guo X; Teng M; Tsao SW; Gewurz BE; Zeng MS; Zhao B
    J Biol Chem; 2019 Jun; 294(25):9734-9745. PubMed ID: 31073033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma.
    Chang SL; Lee SW; Yang SF; Chien CC; Chan TC; Chen TJ; Yang CC; Li CF; Wei YC
    APMIS; 2020 Apr; 128(4):287-297. PubMed ID: 31837171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN3 expression is an independent prognostic factor and associated with advanced tumor stage in nasopharyngeal carcinoma.
    Chang SL; Chen TJ; Lee YE; Lee SW; Lin LC; He HL
    Int J Med Sci; 2018; 15(10):992-998. PubMed ID: 30013440
    [No Abstract]   [Full Text] [Related]  

  • 18. MiR-99a inhibits cell proliferation of nasopharyngeal carcinoma by targeting mTOR and serves as a prognostic factor.
    Wu SH; Han L; Lu BC; Wang HY; Zheng CP
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2053-2061. PubMed ID: 30915749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
    Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
    Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N
    BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.